Chromium
Pronunciation: KROM-ee-um
Class: Trace metal
Trade Names
Chromic Chloride
- Injection chromium 4 mcg/mL (as chromic chloride 20.5 mcg/mL)
Pharmacology
Helps maintain normal glucose metabolism and peripheral nerve function.
Pharmacokinetics
Absorption
Bound to transferrin (siderophilin) in the beta globulin fraction. Typical blood levels range from 1 to 5 mcg/L, but blood levels are not considered a meaningful index of tissue stores.
Elimination
Primarily via the kidney.
Indications and Usage
As a supplement to TPN to help maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency syndromes.
Contraindications
Do not give undiluted by direct IM or IV injection into a peripheral vein; do not give by bolus injection.
Dosage and Administration
Supplementation in Patients Receiving TPNAdults
IV 10 to 15 mcg/day of chromium added to the TPN. Metabolically stable adults with intestinal fluid loss may require 20 mcg/day.
ChildrenIV 0.14 to 0.2 mcg/kg/day of chromium added to the TPN.
Renal Function ImpairmentAdjust or omit dose as needed in severe kidney disease.
General Advice
- Do not give undiluted by direct injection into a peripheral vein.
- Do not give by direct IM or IV injection.
- Add to TPN solution.
Storage/Stability
Store at 59° to 86°F.
Drug Interactions
None well documented.
Adverse Reactions
None well documented.
Precautions
Pregnancy
Category C .
Lactation
Undetermined.
Renal Function
Primarily excreted by the kidneys; adjust or omit dose as needed in severe kidney disease.
Aluminum toxicity
Parenteral products may contain aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk.
Diabetes mellitus
In assessing the contribution of chromium supplements to maintenance of glucose homeostasis, consider the possibility that the patient is diabetic, in which case an antidiabetic agent may be indicated.
Overdosage
Symptoms
Coma, convulsions, GI ulcers, nausea, renal and hepatic damage, vomiting.
Patient Information
- Advise patient that medication will be prepared and administered by a health care provider in a hospital setting.
Copyright © 2009 Wolters Kluwer Health.


